This study’s findings place UC within a particular group of cancers, including renal cell carcinoma, HER2-positive breast cancer, hepatocellular carcinoma, and head and neck cancers, in which HIF-2/EPAS1 expression has prognostic value [42,43,44,45,46]. This evidence concerns the gene ERBB2 and breast cancer.